Hesperos Inc.
Russell Emmons is a seasoned scientist currently serving as the Multi-Organ Team Lead at Hesperos Inc., where leadership in integrating four-organ constructs has led to the acquisition of significant contracts. Prior research experience includes positions as a Postdoctoral Researcher at The University of Memphis and Northwestern University, focusing on aging, atherosclerosis, and immunometabolism, as well as mentoring researchers and developing innovative models in cardiac research. With a robust educational background, including a PhD in Kinesiology and Exercise Science from the University of Illinois Urbana-Champaign and previous roles as a Graduate Research and Teaching Assistant, Russell Emmons combines expertise in multiorgan systems, immune response, exercise physiology, and effective communication skills.
Hesperos Inc.
Hesperos, Inc. is a leader in efforts to characterize an individual's biology with Human-on-a-Chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organsystems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational PKPD modeling of live physiological responses utilizing functional readouts from neurons, cardiac, muscle, barrier tissues and neuromuscular junctions as well as responses from liver, pancreas and barrier tissues.